Reported Q: Q2 2024 Rev YoY: +6.3% EPS YoY: -945.7% Move: +0.50%
Walgreens Boots Alliance
WBA
$11.98 0.50%
Exchange NASDAQ Sector Healthcare Industry Medical Pharmaceuticals
Q2 2024
Published: Mar 28, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for WBA

Reported

Report Date

Mar 28, 2024

Quarter Q2 2024

Revenue

37.05B

YoY: +6.3%

EPS

-6.85

YoY: -945.7%

Market Move

+0.50%

Previous quarter: Q1 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $37.05B up 6.3% year-over-year
  • EPS of $-6.85 decreased by 945.7% from previous year
  • Gross margin of 19.0%
  • Net income of -5.91B
  • ""We expect these impacts to be partially offset by execution in pharmacy services and tax favorability."" - Tim Wentworth
WBA
Walgreens Boots Alliance Inc

Executive Summary

Walgreens Boots Alliance (WBA) reported its Q2 2024 financial results on February 29, 2024, revealing a challenging operating environment impacted negatively by inflation and shifting consumer behaviors. The company's total revenue rose by 6.28% year-over-year to $37.05 billion, yet net income saw a significant decline to a loss of $5.90 billion, primarily due to a hefty $5.8 billion non-cash goodwill impairment charge associated with its investment in VillageMD. Despite this, management highlighted solid performance in the international segment and noted its first quarter of positive Adjusted EBITDA in U.S. Healthcare, positioning the company for potential recovery. Balancing cost reduction initiatives with strategic investments in healthcare solutions remains a focus for management, reflecting their commitment to navigate the retail landscape effectively.

Key Performance Indicators

Revenue
Increasing
37.05B
QoQ: 0.94% | YoY: 6.28%
Gross Profit
Decreasing
7.04B
19.00% margin
QoQ: 3.99% | YoY: -0.21%
Operating Income
Decreasing
-13.17B
QoQ: 33 671.79% | YoY: -6 785.79%
Net Income
Decreasing
-5.91B
QoQ: 8 717.91% | YoY: -940.40%
EPS
Decreasing
-6.85
QoQ: 8 727.32% | YoY: -945.68%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2025 39,459.00 -0.31 +7.5% View
Q4 2024 37,547.00 -3.48 +6.0% View
Q3 2024 36,351.00 0.40 +2.6% View
Q2 2024 37,052.00 -6.85 +6.3% View
Q1 2024 36,707.00 -0.08 +10.0% View